1.
Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking
2.
3.
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
4.
5.
6.
7.
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
8.
9.
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study